Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common Stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2025-12-08
- Filing-level shares
- 538,707.00
- Percent of class
- 4.9%
- Orca Capital AG
Shares: 538,707.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-027252
- Form type
- SCHEDULE 13G/A
- Filer
- Orca Capital AG
- CIK
- CIK 2052389
- Filed
- Dec 11, 2025
- Reporting period
- Dec 08, 2025
- Description
- Schedule 13G beneficial ownership